Published in Ophthalmology on February 01, 2004
Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies. Br J Ophthalmol (2004) 1.28
Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis. PLoS One (2012) 1.18
The management of glaucoma and intraocular hypertension: current approaches and recent advances. Ther Clin Risk Manag (2006) 0.96
Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study. BMC Ophthalmol (2010) 0.95
Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial. Clin Ophthalmol (2012) 0.89
Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%). Clin Ophthalmol (2008) 0.83
Twenty-four hour efficacy with the dorzolamide/timolol-fixed combination compared with the brimonidine/timolol-fixed combination in primary open-angle glaucoma. Eye (Lond) (2011) 0.83
A comparative study on the efficacy, safety, and cost-effectiveness of bimatoprost/timolol and dorzolamide/timolol combinations in glaucoma patients. Indian J Pharmacol (2010) 0.82
Rational use of the fixed combination of dorzolamide - timolol in the management of raised intraocular pressure and glaucoma. Clin Ophthalmol (2008) 0.82
Predictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combination. BMC Ophthalmol (2010) 0.82
Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature. Trials (2008) 0.81
Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg. Clin Ophthalmol (2009) 0.79
Diurnal intraocular pressure with bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in healthy subjects. Korean J Ophthalmol (2014) 0.77
Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension. Clin Ophthalmol (2010) 0.77
Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension. Drug Healthc Patient Saf (2010) 0.76
A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol (2003) 4.35
Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma. Ophthalmology (2011) 2.01
A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol (2006) 1.64
Aqueous shunt exposure: a retrospective review of repair outcome. J Glaucoma (2013) 1.25
Reproducibility of scleral spur identification and angle measurements using fourier domain anterior segment optical coherence tomography. J Ophthalmol (2012) 1.14
Re: "topical tetracaine used for 24 hours is safe and rated highly effective by patients for the treatment of pain caused by corneal abrasions: a double-blind, randomized clinical trial". Acad Emerg Med (2014) 1.10
Interobserver agreement and intraobserver reproducibility of the subjective determination of glaucomatous visual field progression. Ophthalmology (2010) 1.00
Risk factors for tube shunt exposure: a matched case-control study. J Ophthalmol (2013) 0.99
Risk factors for primary open angle glaucoma progression: what we know and what we need to know. Curr Opin Ophthalmol (2008) 0.89
New technology for examining the anterior segment by ultrasonic biomicroscopy. J Cataract Refract Surg (2008) 0.87
"Bleb window"-pexy for the management of symptomatic, oversized blebs. J Glaucoma (2009) 0.84
Combined cataract extraction and Baerveldt glaucoma drainage implant: indications and outcomes. Ophthalmology (2002) 0.83
Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs. Arch Ophthalmol (2010) 0.83
Intermediate term safety and efficacy of transscleral cyclophotocoagulation after tube shunt failure. J Glaucoma (2012) 0.83
Subretinal suture misdirection during 360 degrees suture trabeculotomy. Am J Ophthalmol (2006) 0.82
Effect of Laser Peripheral Iridotomy on Anterior Chamber Angle Anatomy in Primary Angle Closure Spectrum Eyes. J Glaucoma (2016) 0.81
Quantitative assessment of aqueous flare: the effect of age and pupillary dilation. Ophthalmic Surg Lasers (2002) 0.81
Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure. Am J Ophthalmol (2002) 0.81
Age-related changes in trabecular meshwork imaging. Biomed Res Int (2013) 0.80
The effect of intranasal fluticasone propionate irrigations on salivary cortisol, intraocular pressure, and posterior subcapsular cataracts in postsurgical chronic rhinosinusitis patients. Int Forum Allergy Rhinol (2013) 0.79
Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States. J Glaucoma (2005) 0.78
Short-Term Outcomes of KeraSys Patch Graft for Glaucoma Drainage Devices: A Case Series. J Ophthalmol (2013) 0.78
The value of intraocular pressure asymmetry in diagnosing glaucoma. J Glaucoma (2013) 0.77
Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension. Clin Ophthalmol (2010) 0.77
Correlation between intraocular pressure and body mass index in the seated and supine positions. J Glaucoma (2015) 0.76
Comparing Gonioscopy With Visante and Cirrus Optical Coherence Tomography for Anterior Chamber Angle Assessment in Glaucoma Patients. J Glaucoma (2016) 0.75
Comparison of Efficacy and Complications of Cyclophotocoagulation and Second Glaucoma Drainage Device after Initial Glaucoma Drainage Device Failure. J Glaucoma (2017) 0.75
Examiner Handedness and the Effects on Intraocular Pressure Readings Using the Tono-Pen XL. J Glaucoma (2017) 0.75
Intraoperative management of nonfunctioning Ahmed glaucoma valve implant. Ophthalmic Surg Lasers Imaging (2006) 0.75
Long-term Outcome of Argon Laser Peripheral Iridoplasty in the Management of Plateau Iris Syndrome Eyes. J Glaucoma (2017) 0.75
Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine. J Clin Psychopharmacol (2003) 0.75